U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,732 records

Showing results for "secondary".

  1. Maskedstats Nrd 2021 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_CORE.PDF
    January 01, 2021 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT CC/MCC 532 0.00% 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 7,932 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 34,815 0.21% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 1,026

  2. Maskedstats Nrd 2018 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
    January 01, 2018 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 767 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 8,931 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 40,399 … 0.23% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,716 0.01% 849: RADIOTHERAPY

  3. Maskedstats Nrd 2016 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 900 0.01% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 7,722 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 43,153 … 0.25% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 2,495 0.01% 849: RADIOTHERAPY

  4. Maskedstats Nrd 2019 Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
    January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 735 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 8,041 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 41,172 … 0.23% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,752 0.01% 849: RADIOTHERAPY

  5. Maskedstats Nrd 2019 Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
    January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,337 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 15,253 0.04% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 79,498 … 0.22% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 3,504 0.01% 849: RADIOTHERAPY

  6. Maskedstats Nis 2021 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core.PDF
    January 01, 2021 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT CC/MCC 197 0.00% 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 3,234 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 14,465 0.22% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 457

  7. Maskedstats Nis 2017 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
    January 01, 2017 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,560 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 18,230 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 86,405 … 0.24% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 4,195 0.01% 849: RADIOTHERAPY

  8. Maskedstats Nis 2020 Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_V2.PDF
    January 01, 2020 - Distribution for DRG_NOPOA DRG_NoPOA Frequency Percent of Total 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 3,138 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 14,661 0.23% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 543

  9. Maskedstats Nis 2016 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core_Weighted.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 1,730 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 16,285 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 87,820 … 0.25% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 5,030 0.01% 849: RADIOTHERAPY

  10. Maskedstats Nis 2022 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core.PDF
    January 01, 2022 - POORLY DIFFERENT NEOPLASTIC DIAG WITHOUT CC/MCC 203 0.00% 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 3,542 0.05% 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH … CC 13,710 0.21% 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC 465

  11. Maskedstats Nis 2019 Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
    January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 288 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 3,200 0.05% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 16,680 … 0.24% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 732 0.01% 849: RADIOTHERAPY

  12. Kid 2019 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
    January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 65 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 2,830 0.09% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 18,454 … 0.60% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,052 0.03% 849: RADIOTHERAPY

  13. Kid 2016 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
    January 01, 2016 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 93 0.00% 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 2,627 0.08% 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 19,499 … 0.63% 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 1,404 0.05% 849: RADIOTHERAPY

  14. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - Secondary outcomes included mortality and harms. Findings. … programs, daily MAT formulations, XR formulations Outcomes Include* Primary: Treatment retention Secondary … extended-release * Systematic reviews and primary studies were included only if they report the primary or secondary … Findings from a secondary analysis of an RCT that replaced the second half-hour of every in-person counseling … adverse events, ranging from serious fatal and nonfatal adverse events to adverse events presumed secondary

  15. Screening for HIV: A Review of the Evidence for the U.S. Preventive Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
    June 20, 2019 - . † Includes studies of secondary prophylaxis. … these studies found that the cost-effectiveness improved to $15 000 per quality-adjusted life-year when secondary … The other study, which did not di- rectly incorporate secondary transmission benefits into cost-effectiveness … study by Sanders and colleagues (242) found that the model was sensitive to the effects of screening on secondary … Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion

  16. Arthritis-Knee-Physical-Therapy Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
    November 01, 2012 - 1 Comparative Effectiveness Review Number 77 Physical Therapy Interventions for Knee Pain Secondary … This report synthesizes published evidence about the effectiveness of physical therapy for pain secondary … We defined the target population as community-dwelling adults with knee pain secondary to knee OA. … Physical Therapy Interventions for Knee Pain Secondary to Osteoarthritis. … For More Copies For more copies of Physical Therapy Interventions for Knee Pain Secondary to Osteoarthritis

  17. Disposition of Comments_Comparative Effectiveness Review No. 267: ADHD Diagnosis and Treatment in Children and Adolescents (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-disposition-comments.pdf
    March 25, 2024 - The review erroneously concludes that it is effective and can be recommended as a secondary treatment … ADHD is never alone having 65% ED/LD, #) 30% Depression, 35% ODD Learning Disorder is secondary to … Plitzka who said that the right side is poor ly connected in ADHD ( secondary to shutting down sensory

  18. Success Stories from the AHRQ-Funded Health IT Portfolio (2009) (pdf file)

    digital.ahrq.gov/sites/default/files/docs/page/HITSuccessStories112910.pdf
    May 02, 2014 - This project consisted of three parts: 1) analyses of secondary data to compare indicators of the quality … “Personal Health Information Management and the Design of Consumer Health Information Technology: Secondary … Personal Health Information and the Design of Consumer Health Information Technology: Secondary Analysis

  19. AHRQ Health Information Technology Portfolio’s 2009 Annual Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/page/Abridged_ReportHIT2009.pdf
    November 17, 2011 - studies, including: 1) small pilot and feasibility or self-contained health IT research projects, 2) secondary …  Health IT Secondary Data Analysis investigates additional research questions that are related … However, these requisite dissemination requirements would likely be secondary to the business goals

  20. Disposition of Comments for CER 208 Treatment for Bipolar Disorder in Adults A Systematic Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
    August 07, 2018 - opinion, the suggestions the authors offer for enhancing retention in clinical trials – “multiple secondary … complexity of bipolar disorder itself (e.g, by subtype, mood episode polarity, acute treatment vs. secondary … symptom polarity outcomes, choice to focus on acute phase treatment, maintenance phase treatment, or secondary
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1196)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (695)

digital.ahrq.gov (428)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (16)

integrationacademy.ahrq.gov (8)

meps.ahrq.gov (7)

datatools.ahrq.gov (4)

qualityindicators.ahrq.gov (4)

pso.ahrq.gov (2)